As AI-driven scientific research accelerates the drug discovery process, much of the attention has focused on the impact of new models, algorithms and compute.
As antibody therapeutics continue their rapid advance, structural biology is producing unprecedented volumes of data, from Cryo-EM, X-ray crystallography